Immunotherapy with autologous, human dendritic cells transfected with carcinoembryonic antigen mRNA. (Record no. 12676367)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01945 a2200565 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250514074603.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 200309s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 0735-7907 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1081/cnv-120018224 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Morse, Michael A |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20030923 |
| 245 00 - TITLE STATEMENT | |
| Title | Immunotherapy with autologous, human dendritic cells transfected with carcinoembryonic antigen mRNA. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | Cancer investigation |
| Date of publication, distribution, etc. | Jun 2003 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 341-9 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Adult |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Carcinoembryonic Antigen |
| General subdivision | adverse effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Colonic Neoplasms |
| General subdivision | pathology |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Dendritic Cells |
| General subdivision | physiology |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Dose-Response Relationship, Drug |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Female |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Immunotherapy |
| General subdivision | methods |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Leukapheresis |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Liver Neoplasms |
| General subdivision | secondary |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Male |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Middle Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | RNA, Messenger |
| General subdivision | genetics |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Recombinant Proteins |
| General subdivision | therapeutic use |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Survival Analysis |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Transfection |
| General subdivision | methods |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Transplantation, Autologous |
| General subdivision | adverse effects |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Nair, Smita K |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Mosca, Paul J |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Hobeika, Amy C |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Clay, Timothy M |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Deng, Yuping |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Boczkowski, David |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Proia, Alan |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Neidzwiecki, Donna |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Clavien, Pierre-A |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Hurwitz, Herbert I |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Schlom, Jeffrey |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Gilboa, Eli |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Lyerly, H Kim |
| 773 0# - HOST ITEM ENTRY | |
| Title | Cancer investigation |
| Related parts | vol. 21 |
| -- | no. 3 |
| -- | p. 341-9 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1081/cnv-120018224">https://doi.org/10.1081/cnv-120018224</a> |
| Public note | Available from publisher's website |
No items available.